Occupational Therapists in Claymont, DE Accepting Medicare
8 Occupational Therapists found. Showing 1 - 8
 Susan Birch Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Pennsylvania Ave, Claymont, DE 19703 Phone: 302-792-3994 |
Karen Virion Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Pennsylvania Ave, Claymont, DE 19703 Phone: 302-792-3994 |
Jillian Kerr, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 910 Aldon Rd, Claymont, DE 19703 Phone: 302-798-4608 |
Suzanne Sager, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1112 Lighthorse Lane, Claymont, DE 19703 Phone: 814-558-9835 |
Katie Oakley Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Pennsylvania Ave, Claymont, DE 19703 Phone: 302-792-3937 |
Sandy Hetrick Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Pennsylvania Ave, Claymont, DE 19703 Phone: 302-792-3994 |
Kelly Adair-naseery Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Pennsylvania Ave, Claymont, DE 19703 Phone: 302-792-3994 |
Corinne Prikockis Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Pennsylvania Ave, Claymont, DE 19703 Phone: 302-792-3994 |
News Archive
Study explores use of bisphosphonates for men receiving androgen deprivation therapy
Although some guidelines recommend use of bisphosphonates (a class of drugs used to strengthen bone) for men on androgen deprivation therapy, an analysis finds that prescriptions for these drugs remains low, even for those men at high risk of subsequent fractures, according to a study in the December 3 issue of JAMA.
Shire to enter European ADHD market with acquisition of EQUASYM IR and XL
Shire plc has announced that it has signed an agreement with UCB to acquire the worldwide rights to EQUASYM IR and XL (methylphenidate hydrochloride) (excluding the USA, Canada and Barbados) used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
More U.S. investment in diplomacy, development needed, say former military leaders
A group of former U.S. military leaders have joined "recent calls by Defense Secretary Robert Gates and Chairman of the Joint Chiefs of Staff Adm. Michael Mullen to expand U.S. civilian capacities to reduce dependence on the military," Politico's Laura Rozen reports on her blog.
MiMedx posts record revenue of $49M in Q3 2014
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and the Dental sectors of healthcare, announced today its record revenue results for the third quarter of 2015, its guidance for the fourth quarter of 2015, and that the Company has secured a $50 million Senior Secured Credit Facility.
Plastic surgeons caution against unknown dangers of mesotherapy
The allure of shedding unwanted pockets of fat with a series of simple injections, known as mesotherapy, sounds too good to be true - and it just might be. According to an ASPS Device & Technique Assessment (DATA) Committee report published in the April 15 issue of Plastic and Reconstructive Surgery® (PRS), the official medical journal of the American Society of Plastic Surgeons (ASPS), patients should be wary of mesotherapy until the safety and effectiveness of the procedure are confirmed.
› Verified 3 days ago
Occupational Therapists
Speech-Language Pathologists
Physical Therapists
Chiropractors
Optometrists
Podiatrists